U.S. Specialty Stores Stock News

NYSE:ASPN
NYSE:ASPNChemicals

A Look At Aspen Aerogels (ASPN) Valuation After Steep Losses And Manufacturing Impairment

Why Aspen Aerogels is back in focus Aspen Aerogels (ASPN) is back on investors’ radar after reporting a sharp year over year revenue decline, a large full year net loss, a sizeable impairment charge, and guidance indicating continued losses. See our latest analysis for Aspen Aerogels. The stock’s recent swings reflect this reset in expectations, with a 7 day share price return showing a 13.57% decline and a 1 year total shareholder return indicating a 59% loss, highlighting how pressure has...
NYSE:AS
NYSE:ASLuxury

Is Amer Sports (AS) Pricing In Too Much Optimism After Recent Share Price Swings?

If you are wondering whether Amer Sports at around US$37.98 is offering good value or not, you are not alone. This article is here to unpack that question clearly. The stock has had a mixed run, with a 9.5% decline over the last 7 days, a 3.7% gain over the past month, and a 27.1% return over the last year, which can change how investors think about both upside and risk. Recent news coverage has focused on Amer Sports as a consumer durables name that investors are watching for how it...
NYSE:SDRL
NYSE:SDRLEnergy Services

Seadrill’s Record Safety And Contract Wins Set Stage For 2026 Earnings

Seadrill (NYSE:SDRL) reported record operational and safety performance, marking its best safety results to date. The company secured several long term contracts, including a key award in Malaysia in the deepwater segment. Management highlighted strong execution on complex offshore projects alongside ongoing market challenges such as high reactivation costs and regional softness. At a share price of $43.88, Seadrill is drawing attention as it pairs operational execution with what the...
NYSE:FRO
NYSE:FROOil and Gas

Frontline (NYSE:FRO) Margin Compression Challenges Bullish Earnings Growth Narrative

Frontline (NYSE:FRO) has capped FY 2025 with fourth quarter revenue of US$624.5 million and EPS of US$1.02, while trailing twelve month revenue sits at US$1.97 billion and EPS at US$1.70. The company has seen quarterly revenue move from US$425.6 million and EPS of US$0.30 in Q4 2024 to US$624.5 million and EPS of US$1.02 in Q4 2025, giving investors a clear view of how the top line and per share earnings have tracked over the past year as they weigh these results against margins and overall...
NasdaqGS:CBSH
NasdaqGS:CBSHBanks

Waterford Advisors Sparks Fresh Look At Commerce Bancshares Valuation And Dividends

Waterford Advisors, LLC has opened a significant new position in Commerce Bancshares, indicating fresh institutional interest in the bank. The move highlights investor focus on NasdaqGS:CBSH during a period of weaker recent share price performance. Commerce Bancshares continues to be associated with a strong capital position and a track record of consistent dividend increases. Commerce Bancshares, traded as NasdaqGS:CBSH, last closed at $50.99, with the share price showing declines of 5.6%...
NYSE:MTZ
NYSE:MTZConstruction

MasTec Record Results And Acquisitions Reshape Growth And Backlog Outlook

MasTec (NYSE:MTZ) reported record full year results, with revenue and earnings above its prior guidance. The company highlighted a substantial increase in its contracted backlog, pointing to a fuller pipeline of future work. MasTec completed the acquisitions of NV2A and McKee Utility Contractors to build out its data center and water infrastructure construction management capabilities. For investors watching MasTec, the latest update provides fresh numbers on the company’s recent...
NYSE:FBK
NYSE:FBKBanks

FB Financial Merger Shifts Growth Focus While Valuation Shows Potential Upside

FB Financial (NYSE:FBK) has agreed to merge with Southern States Bancshares, expanding its banking footprint in Alabama and Georgia. The deal brings together two regional institutions with complementary branch networks and customer bases in the southeastern U.S. Management has outlined plans to integrate operations while focusing on market penetration, talent development and potential future acquisitions. FB Financial enters this merger with shares at $54.69 and a 1 year return of 9.9%,...
NasdaqGM:RDNT
NasdaqGM:RDNTHealthcare

Is It Too Late To Reassess RadNet (RDNT) After Its Strong Multi Year Share Price Run

If you are wondering whether RadNet's share price still reflects fair value after a strong multi year run, you are not alone. This article will walk through what the numbers actually say. RadNet recently closed at US$69.81, with returns of a 0.4% decline over 7 days, a 2.6% decline over 30 days, a 1.6% decline year to date, and a 25.9% gain over 1 year, as well as a very large gain over 5 years that may have reshaped expectations around risk and opportunity. Recent news around RadNet has...
NYSE:WMK
NYSE:WMKConsumer Retailing

Weis Markets Restatement Raises Questions On Valuation And Earnings Quality

Weis Markets (NYSE:WMK) has delayed filing its annual Form 10 K as it works through a restatement of historical financial statements. The restatement is tied to errors identified in inventory accounting and related internal control issues. The company is reviewing potential material weaknesses in its financial reporting processes before submitting the updated filing. Weis Markets operates a regional supermarket chain, so reliable inventory accounting is central to how investors evaluate its...
NYSE:BHC
NYSE:BHCPharmaceuticals

Assessing Bausch Health (BHC) Valuation After Years Of Weak Returns And Ongoing Debt Reduction Efforts

Why Bausch Health Companies (BHC) Is On Investors’ Radar Today Bausch Health Companies (BHC) has come into focus after recent trading left the share price around $5.93. This has prompted investors to reassess the diversified healthcare group’s mixed return profile and current valuation signals. See our latest analysis for Bausch Health Companies. The recent pullback, with a 1 day share price return of 1.82% decline and a year to date share price return of 17.75% decline, contrasts with a 1...
NYSE:QBTS
NYSE:QBTSSoftware

Is D-Wave Quantum (QBTS) Pricing Reflect Recent Quantum Computing Headlines And Sharp Share Swings

If you are trying to figure out whether D-Wave Quantum's share price makes sense right now, you are not alone. This article looks closely at what the current market value might be telling you about the business. The stock has been volatile, with a 4% move over the last week, a 24.8% decline over 30 days, a 33.2% decline year to date, and a 242.7% return over the past year, alongside a very large return over three years and an 85.8% return over five years. Recent headlines have focused on...
NYSE:CUBE
NYSE:CUBESpecialized REITs

CubeSmart (CUBE) Margin Compression Challenges Income Focus Narrative After FY 2025 Results

CubeSmart (CUBE) has just wrapped up FY 2025 with fourth quarter revenue of US$282.7 million and basic EPS of US$0.34, while trailing twelve month revenue sits at US$1.1 billion and EPS at US$1.46, giving investors a clear read on the top and bottom line heading into the new year. Over recent periods, the company has seen revenue move from US$268.5 million and EPS of US$0.45 in Q4 2024 to US$282.7 million and EPS of US$0.34 in Q4 2025, alongside trailing twelve month EPS shifting from US$1.73...
NYSE:PK
NYSE:PKHotel and Resort REITs

Park Hotels Ties Finance And Operations With Sean Dell’Orto Promotion

Park Hotels & Resorts (NYSE:PK) has appointed Sean M. Dell’Orto as Chief Operating Officer, adding to his existing roles as Chief Financial Officer and Treasurer. The expanded role gives Dell’Orto broader oversight of operations alongside his current finance responsibilities. For Park Hotels & Resorts, which last closed at $11.31, this leadership shift puts one executive at the center of both financial and operational decisions. The stock shows mixed performance, with a 5.4% return over the...
NasdaqGS:IMCR
NasdaqGS:IMCRBiotechs

Is It Time To Reassess Immunocore (IMCR) After Recent Biotech Progress And Valuation Signals

If you are wondering whether Immunocore Holdings is priced attractively right now, this article will walk through how its current share price stacks up against several valuation checks. The stock last closed at US$32.30, with a 10.0% return over the past year but declines of 1.2% over 7 days, 2.5% over 30 days and 4.4% year to date. These movements can change how investors think about both upside potential and risk. Recent news around Immunocore has focused on its position within the...
NasdaqGS:ZD
NasdaqGS:ZDInteractive Media and Services

Ziff Davis Refocuses On Core Business As RetailMeNot Bets On Cash Back

RetailMeNot, a Ziff Davis (NasdaqGS:ZD) company, has launched a Guaranteed Cash Back program that offers assured and stackable rewards for shoppers. Ziff Davis completed its exit from the Games Publishing business in Q4 2025, refocusing on its core operations. For you as an investor, these moves sit at the heart of what Ziff Davis does today: a mix of digital media, subscription based services, and advertising supported platforms. RetailMeNot’s Guaranteed Cash Back program reflects how...
NasdaqGM:CRMD
NasdaqGM:CRMDPharmaceuticals

CorMedix Expands With Melinta Buy As Valuation Gap Draws Attention

CorMedix (NasdaqGM:CRMD) has agreed to acquire Melinta Therapeutics, adding seven approved therapies to its commercial portfolio. The transaction expands CorMedix's presence in hospital and acute care settings through a broader anti infective offering. The deal marks a shift from a single product focused model toward a multi asset commercial platform. For you as an investor, CorMedix has largely been known for its focus on infection prevention products in high risk settings. By bringing...
NasdaqGS:DNUT
NasdaqGS:DNUTHospitality

Assessing Krispy Kreme (DNUT) Valuation After The New Oreo Doughnut Collection Launch

Krispy Kreme (DNUT) is back in the spotlight after expanding its collaboration with the Oreo brand, rolling out a limited time cookie themed doughnut collection that sits alongside its recent earnings release. See our latest analysis for Krispy Kreme. The Oreo collaboration and recent earnings update come after a sharp rebound in the short term, with a 7 day share price return of 23.76% and 30 day share price return of 18.67%. However, this sits against a 1 year total shareholder return...
NasdaqGS:INTU
NasdaqGS:INTUSoftware

Intuit (INTU) Margin Expansion Tests Bearish Spending Narratives After Q2 2026 Results

Intuit (INTU) has put solid numbers on the board for Q2 2026, with revenue of US$4.7b, basic EPS of US$2.48 and net income of US$693m, backed by trailing 12 month EPS of US$15.53 on revenue of US$20.1b. The company has seen quarterly revenue shift from US$3.9b in Q2 2025 to US$4.7b in Q2 2026, while basic EPS moved from US$1.68 to US$2.48 over the same period. This sets the context for trailing earnings growth of 42.9% and a net margin of 21.6%. For investors, the combination of higher recent...
NYSE:ENOV
NYSE:ENOVMedical Equipment

Enovis Weighs US$501.3m Impairment Against Nebula Led Organic Growth

Enovis (NYSE:ENOV) recorded a goodwill impairment charge of over $500 million in Q4 2025, tied to changes in its business mix and accounting assumptions. The company reported strong organic growth in key segments in the same period, supported by new product launches. Recently introduced products, including the Nebula Stem and OrthoDrive Impactor, are gaining traction, with Nebula competing directly against established peers. For investors tracking Enovis, the combination of a large goodwill...
NasdaqGS:MBLY
NasdaqGS:MBLYAuto Components

Mobileye Deepens ADAS Partnerships And Moves Closer To Level 4 Scale

Mobileye Global (NasdaqGS:MBLY) is adding Elektrobit’s Linux platform to its Mobileye Drive system to support Level 4 autonomous driving. The company recently secured a major U.S. OEM win for its advanced driver assistance systems, expanding its ADAS pipeline. Mobileye signed a SuperVision agreement with Mahindra & Mahindra, positioning itself as a Tier 1 supplier and opening new geographic markets. Mobileye Global, known for its driver assistance and autonomous driving technology, is...
NasdaqGS:AVAH
NasdaqGS:AVAHHealthcare

Is Aveanna Healthcare Holdings (AVAH) Still Attractively Priced After Its Recent Multi Year Surge

If you are wondering whether Aveanna Healthcare Holdings is still attractively priced after its recent run, you are not alone. This article focuses on what the current share price could imply about value. The stock last closed at US$7.36, with returns of 0.3% over 7 days, a 10.8% decline over 30 days, an 8.9% decline year to date, and a 72.8% gain over the past year, as well as a very large 3 year return of around 4x. Recent coverage has centred on Aveanna's role in home and pediatric...
NasdaqGS:QURE
NasdaqGS:QUREBiotechs

Does The Share Price Of uniQure (QURE) Reflect Its Gene Therapy Prospects?

If you are wondering whether uniQure’s current share price reflects its true worth, this breakdown is designed to help you weigh what you are paying against what you are getting. The stock closed at US$15.63, with returns of a 33.3% decline over 7 days, a 32.1% decline over 30 days, a 33.2% decline year to date, but an 18.9% gain over the past year, which may catch the eye of investors thinking about both risk and recovery potential. Recent news around uniQure has focused on its position in...
NasdaqGM:LMAT
NasdaqGM:LMATMedical Equipment

LeMaitre Vascular Links Strong 2025 Results To Higher Shareholder Returns

LeMaitre Vascular (NasdaqGM:LMAT) reported robust Q4 2025 and full-year 2025 financial results. The company announced a new US$100 million share repurchase program. Management approved a 25% dividend increase for shareholders. LeMaitre Vascular focuses on medical devices for vascular surgeons, so its performance tends to track demand for procedures that treat peripheral vascular disease and related conditions. The combination of strong quarterly and full-year 2025 figures with higher...
NYSE:NLY
NYSE:NLYMortgage REITs

Annaly Insider Sale Prompts Fresh Look At Valuation And Dividend Risk

A senior executive at Annaly Capital Management (NYSE:NLY) has sold company shares, according to a recent regulatory filing. The transaction involves insider ownership of the mortgage real estate investment trust and comes at a time when there is limited company specific news. Annaly Capital Management focuses on investing in mortgage related assets, a segment that is closely linked to interest rate policy, housing finance conditions, and broader credit markets. When an insider at a company...